Publications by authors named "Lacin Cevhertas"

Introduction: Eosinophilic esophagitis (EoE) is a chronic inflammatory condition with an incompletely understood immuno-pathogenesis involving a T2 response. EoE is triggered by food allergens although, unlike IgE-mediated allergies, it exhibits high IgG4 levels in oesophageal biopsies and in circulation. We investigated whether other antibody isotypes specific for food allergens are elevated in EoE and vary with disease activity.

View Article and Find Full Text PDF

Background: Immune checkpoint inhibitors (ICIs) are among the most promising treatment options for melanoma and non-small cell lung cancer (NSCLC). While ICIs can induce effective anti-tumor responses, they may also drive serious immune-related adverse events (irAEs). Identifying biomarkers to predict which patients will suffer from irAEs would enable more accurate clinical risk-benefit analysis for ICI treatment and may also shed light on common or distinct mechanisms underpinning treatment success and irAEs.

View Article and Find Full Text PDF

Pollution in the world and exposure of humans and nature to toxic substances is continuously worsening at a rapid pace. In the last 60 years, human and domestic animal health has been challenged by continuous exposure to toxic substances and pollutants because of uncontrolled growth, modernization, and industrialization. More than 350,000 new chemicals have been introduced to our lives, mostly without any reasonable control of their health effects and toxicity.

View Article and Find Full Text PDF
Article Synopsis
  • There's been a rise in allergic diseases globally, driven by a type 2 immune response involving various immune cells, leading to significant medical and economic impacts.
  • Biomarkers play a crucial role in precision medicine by aiding in disease classification, diagnosis, therapy targeting, and treatment evaluation, with advancements in omics technologies enhancing their identification.
  • Recent research has focused on potential biomarkers for allergic diseases like asthma and atopic dermatitis, including sputum eosinophils and serum periostin, while also considering the implications of COVID-19 on managing these conditions.
View Article and Find Full Text PDF

The "epithelial barrier hypothesis" proposes that the exposure to various epithelial barrier-damaging agents linked to industrialization and urbanization underlies the increase in allergic diseases. The epithelial barrier constitutes the first line of physical, chemical, and immunological defense against environmental factors. Recent reports have shown that industrial products disrupt the epithelial barriers.

View Article and Find Full Text PDF

B cells play a central role in the immune system through the production of antibodies. During the past two decades, it has become increasingly clear that B cells also have the capacity to regulate immune responses through mechanisms that extend beyond antibody production. Several types of human and murine regulatory B cells have been reported that suppress inflammatory responses in autoimmune disease, allergy, infection, transplantation, and cancer.

View Article and Find Full Text PDF

B cells have classically been recognized for their unique and indispensable role in the production of antibodies. Their potential as immunoregulatory cells with anti-inflammatory functions has received increasing attention during the last two decades. Herein, we highlight pioneering studies in the field of regulatory B cell (Breg) research.

View Article and Find Full Text PDF

Purpose Of Review: Allergen immunotherapy is the only treatment modality which alters the natural course of allergic diseases by restoring immune tolerance against allergens. Deeper understanding of tolerance mechanisms will lead to the development of new vaccines, which target immune responses and promote tolerance.

Recent Findings: Successful allergen immunotherapy (AIT) induces allergen-specific peripheral tolerance, characterized mainly by the generation of allergen-specific Treg cells and reduction of Th2 cells.

View Article and Find Full Text PDF
Article Synopsis
  • * Key findings highlight the importance of genetic, epigenetic, and environmental factors, as well as the significance of understanding molecular and immune mechanisms for developing new therapies.
  • * The review also addresses challenges in asthma management prompted by recent pandemics, focusing on how asthma interacts with COVID-19 and its implications for patient care.
View Article and Find Full Text PDF

Allergen-specific immunotherapy (AIT) is the mainstay treatment for the cure of allergic disorders, with depicted efficacy and safety by several trials and meta-analysis. AIT impressively contributes to the management of allergic rhinitis, asthma and venom allergies. Food allergy is a new arena for AIT with promising results, especially via novel administration routes.

View Article and Find Full Text PDF

The main interfaces controlling and attempting to homeostatically balance communications between the host and the environment are the epithelial barriers of the skin, gastrointestinal system, and airways. The epithelial barrier constitutes the first line of physical, chemical, and immunologic defenses and provides a protective wall against environmental factors. Following the industrial revolution in the 19th century, urbanization and socioeconomic development have led to an increase in energy consumption, and waste discharge, leading to increased exposure to air pollution and chemical hazards.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how clinical, immunological, and genetic factors influence patient responses to anti-TNFα and interleukin-12/23 therapies, along with drug survival rates.
  • It involved 180 patients, divided into two groups: one with patients on multiple biologic agents (group A) and another with biologic-naive patients (group B), analyzing data and anti-drug antibodies through ELISA and HLA typing.
  • Key findings showed that infliximab had the best drug survival and etanercept had the lowest antibody count, while factors like HLA-Cw6 negativity, late-onset psoriasis, smoking, and alcohol use were linked to treatment failure in group A.
View Article and Find Full Text PDF